Parlotones back HIV research
The vaccine is the first of its kind that doesn't contain any living or non-living virus.
JOHANNESBURG - South African band The Parlotones have thrown their support behind new HIV vaccine research.
The Immunity Project vaccine is the first of its kind that doesn't contain any living or non-living virus, giving it the potential to be among the safest vaccines ever developed.
Band manager Raphael Domalik has taken on the role of strategic relations director for the project and has been working closely with the Immunity Project team to develop a fundraising strategy for the vaccine's clinical trials in South Africa.
Phase one clinical testing is planned to begin in Durban in 2014, moving rapidly into phase two testing the following year.
All funding is being gathered on a not-for-profit basis.